Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001082217 | SCV000289956 | benign | Spastic paraplegia | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000372721 | SCV000338243 | likely benign | not specified | 2016-01-08 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000334685 | SCV000383364 | uncertain significance | Charlevoix-Saguenay spastic ataxia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000710205 | SCV000614949 | benign | not provided | 2017-09-29 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000334685 | SCV000744369 | likely benign | Charlevoix-Saguenay spastic ataxia | 2015-09-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000710205 | SCV001795691 | likely benign | not provided | 2021-05-25 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000710205 | SCV001961395 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | SACS: BP4, BP7, BS2 |
Genome- |
RCV000334685 | SCV002026660 | benign | Charlevoix-Saguenay spastic ataxia | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001847975 | SCV002105026 | likely benign | Hereditary spastic paraplegia | 2021-10-12 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000334685 | SCV000733202 | likely benign | Charlevoix-Saguenay spastic ataxia | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000334685 | SCV001464172 | benign | Charlevoix-Saguenay spastic ataxia | 2020-05-02 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000710205 | SCV001931869 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003929985 | SCV004739150 | likely benign | SACS-related disorder | 2019-03-21 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |